Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies

Published:2024-01 Issue: Volume: Page:103885
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Jin Haochun,Cui Dianxin,Fan Yu,Li Guodong^ORCID,Zhong Zhangfeng,Wang Yitao

Funder

National Natural Science Foundation of China

Fund for the Development of Science and Technology

University of Macau Research Services and Knowledge Transfer Office

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference108 articles.

1. Molecular networking as a natural products discovery strategy;Zhang;Acta Mater Med,2023

2. Computer-aided drug design: an innovative tool for modeling;Kore;O J Med Chem,2012

3. A robust photoluminescence screening assay identifies uracil-DNA glycosylase inhibitors against prostate cancer;Li;Chem Sci,2020

4. Advances in applying computer-aided drug design for neurodegenerative diseases;Salman;Int J Mol Sci,2021

5. Recent advances in bio-affinity chromatography for screening bioactive compounds from natural products;Guo;J Pharm Biomed Anal,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP